In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers
- PMID: 19174954
In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers
Abstract
This investigation studied the effect of vehicles on the in vitro permeation of carvedilol from saturated solutions across porcine skin and selected appropriate penetration enhancers. Labrasol, Transcutol, polyethylene glycol 400, propylene glycol, ethanol, oleic acid, isopropyl myristate, and phosphate buffered saline (pH 7.4) containing 40% v/v polyethylene glycol 400 as control, were used as vehicles; limonene, carvone, camphor, menthol, Transcutol, and Labrasol at 5% w/v concentrations were used as penetration enhancers. Skin permeation studies were conducted in Franz diffusion cells using excised porcine ear skin. Solubility was highest (369.13 mg/mL) in Transcutol, whereas isopropyl myristate showed the lowest solubility (0.79 mg/mL) among all the vehicles. The flux of carvedilol from Transcutol, Labrasol, polyethylene glycol 400, ethanol, and oleic acid was 10.5, 8.6, 4.2, 2.9, and 1.5 times higher, respectively, than that observed with control. The flux obtained using Transcutol was significantly higher (P < 0.05) than the flux obtained using the other vehicles. However, the flux values of carvedilol using isopropyl myristate (P < 0.01) and propylene glycol (P < 0.05) were significantly lower than that of the control. Solutions containing 5% w/v camphor showed maximum permeation (232.54 microg) in 24 h with a flux of 3.19 microg/cm2/h, which was significantly different (P < 0.05) than the flux obtained using other permeation enhancers. The control sample showed lowest permeation (30.50 microg), with a flux of 0.33 microg/cm2/h. The flux of carvedilol from the solutions containing 5% w/v camphor, limonene, Transcutol, carvone, Labrasol, and menthol were 9.7, 7.6, 7.6, 6.3, 4.7, and 2.3 times higher, respectively, than that observed using the control. The present study suggests that Transcutol, Labrasol, and polyethylene glycol 400 may be used as potential vehicles and camphor, limonene, and Transcutol at a 5% w/v level as penetration enhancers.
Similar articles
-
Influence of sonophoresis and chemical penetration enhancers on percutaneous transport of penbutolol sulfate.Pharm Dev Technol. 2016 Dec;21(8):990-995. doi: 10.3109/10837450.2015.1086373. Epub 2015 Sep 18. Pharm Dev Technol. 2016. PMID: 26383739
-
Transdermal delivery of ketorolac tromethamine: effects of vehicles and penetration enhancers.Drug Dev Ind Pharm. 2004 Jul;30(6):557-64. doi: 10.1081/ddc-120037486. Drug Dev Ind Pharm. 2004. PMID: 15285328
-
Transdermal permeation of Kaempferia parviflora methoxyflavones from isopropyl myristate-based vehicles.AAPS PharmSciTech. 2014 Aug;15(4):947-55. doi: 10.1208/s12249-014-0122-y. Epub 2014 May 3. AAPS PharmSciTech. 2014. PMID: 24789664 Free PMC article.
-
Skin Penetration and Permeation Properties of Transcutol® in Complex Formulations.AAPS PharmSciTech. 2024 Sep 5;25(7):201. doi: 10.1208/s12249-024-02886-8. AAPS PharmSciTech. 2024. PMID: 39235493 Review.
-
[Modelling of pecutaneous drug permeation and investigation of penetration enhancer effect].Acta Pharm Hung. 2012;82(1):15-22. Acta Pharm Hung. 2012. PMID: 22570983 Review. Hungarian.
Cited by
-
Topical Delivery of Carvedilol Loaded Nano-Transfersomes for Skin Cancer Chemoprevention.Pharmaceutics. 2020 Nov 27;12(12):1151. doi: 10.3390/pharmaceutics12121151. Pharmaceutics. 2020. PMID: 33260886 Free PMC article.
-
Enhanced Transdermal Delivery of Bisoprolol Hemifumarate via Combined Effect of Iontophoresis and Chemical Enhancers: Ex Vivo Permeation/In Vivo Pharmacokinetic Studies.Pharmaceutics. 2021 May 10;13(5):682. doi: 10.3390/pharmaceutics13050682. Pharmaceutics. 2021. PMID: 34068544 Free PMC article.
-
Electroanalysis Applied to Compatibility and Stability Assays of Drugs: Carvedilol Study Case.Pharmaceuticals (Basel). 2020 Apr 17;13(4):70. doi: 10.3390/ph13040070. Pharmaceuticals (Basel). 2020. PMID: 32316568 Free PMC article.
-
Topical carvedilol delivery prevents UV-induced skin cancer with negligible systemic absorption.Int J Pharm. 2022 Jan 5;611:121302. doi: 10.1016/j.ijpharm.2021.121302. Epub 2021 Nov 15. Int J Pharm. 2022. PMID: 34793935 Free PMC article.
-
Is Camphor the Future in Supporting Therapy for Skin Infections?Pharmaceuticals (Basel). 2024 May 31;17(6):715. doi: 10.3390/ph17060715. Pharmaceuticals (Basel). 2024. PMID: 38931382 Free PMC article. Review.